title: DOX-Cu9S5@mSiO2-PG composite fibers for orthotopic synergistic chemo- and photothermal tumor therapy.
abstract: A composite antitumor drug carrier platform, in which antitumor drug doxorubicin (DOX) loaded core-shell structured Cu9S5@mSiO2 nanoparticles were incorporated into poly(ε-caprolactone) and gelatin to form nanofibrous fabrics using an electrospinning process, was successfully assembled. The resultant multifunctional spun pieces could be implanted directly to the tumor site of mice using surgical procedures to achieve the orthotopic synergistic therapy combining the chemotherapy of the controlled release of DOX from mesoporous SiO2 with the photothermal treatment through the performance of the photothermal transformation of Cu9S5 under 980 nm laser irradiation in vivo. The experimental results in vivo demonstrated that the synergistic chemotherapy/photothermal treatment of DOX loaded Cu9S5@mSiO2 composite fibers under 980 nm laser irradiation has a more efficient tumor suppression effect, compared with a single chemotherapy of DOX loaded Cu9S5@mSiO2 composite fibers without the 980 nm laser irradiation or a single photothermal treatment from Cu9S5@mSiO2 composite fibers under 980 nm laser irradiation.
authors.affiliation: State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, P. R. China. jlin@ciac.ac.cn cxli@ciac.ac.cn.
authors.forename: Yinyin
authors.initials: Y
authors.lastname: Chen
authors.forename: Zhiyao
authors.initials: Z
authors.lastname: Hou
authors.forename: Bei
authors.initials: B
authors.lastname: Liu
authors.forename: Shanshan
authors.initials: S
authors.lastname: Huang
authors.forename: Chunxia
authors.initials: C
authors.lastname: Li
authors.forename: Jun
authors.initials: J
authors.lastname: Lin
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000494:pharmacology; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D003300:Copper / Q000737:chemistry* / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000737:chemistry* / Q000494:pharmacology; D004337:Drug Carriers / Q000737:chemistry / Q000494:pharmacology; D006367:HeLa Cells; D006358:Hot Temperature / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D057139:Nanofibers / Q000737:chemistry*; D012822:Silicon Dioxide / Q000737:chemistry* / Q000494:pharmacology; D013455:Sulfur / Q000737:chemistry* / Q000494:pharmacology; D023041:Xenograft Model Antitumor Assays / Q000379:methods
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers; D013455:Sulfur; D012822:Silicon Dioxide; D003300:Copper; D004317:Doxorubicin